SELLAS Life Sciences Group Inc Stock, NASDAQ:SLS
Times Square Tower, 7 Times Square, New York, New York 10036
United States of America
Number of Employees: 17
SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S and nelipepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.